D
Emergent BioSolutions Inc. EBS
$5.71 $0.203.63%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -29.61% 8.61% -24.62% 82.84% -16.23%
Total Other Revenue -- -- -- -- --
Total Revenue -29.61% 8.61% -24.62% 82.84% -16.23%
Cost of Revenue -45.81% -27.23% 49.28% -15.38% -50.25%
Gross Profit -19.33% 77.71% -153.08% 679.42% 48.03%
SG&A Expenses -32.10% -4.77% -15.33% -11.94% -4.28%
Depreciation & Amortization 0.62% 0.00% 1.24% -4.71% -9.50%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -37.58% -19.08% 28.55% -13.68% -2.57%
Operating Income 89.81% 2,100.00% -1,094.38% 128.92% -1,506.67%
Income Before Tax 49.36% 153.55% -7.83% 107.53% 11.24%
Income Tax Expenses 174.00% 1,204.00% 18.75% -87.89% -189.29%
Earnings from Continuing Operations 36.77% 143.58% -8.30% 104.83% 26.12%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 36.77% 143.58% -8.30% 104.83% 26.12%
EBIT 89.81% 2,100.00% -1,094.38% 128.92% -1,506.67%
EBITDA 255.56% 319.31% -373.96% 164.17% -154.88%
EPS Basic 39.45% 142.52% -4.39% 104.65% 28.96%
Normalized Basic EPS 60.53% 412.69% -1,003.10% 107.73% -1,541.75%
EPS Diluted 39.22% 140.51% -4.30% 104.58% 28.96%
Normalized Diluted EPS 60.53% 398.63% -1,003.10% 107.73% -1,541.75%
Average Basic Shares Outstanding 4.43% 2.51% 3.75% 3.98% 4.01%
Average Diluted Shares Outstanding 4.43% 7.34% 3.75% 3.98% 4.01%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings